AI-EMERGE Trademark

Trademark Overview

On Monday, May 21, 2018, a trademark application was filed for AI-EMERGE with the United States Patent and Trademark Office. The USPTO has given the AI-EMERGE trademark a serial number of 87929768. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 27, 2026. This trademark is owned by Freenome Holdings, Inc.. The AI-EMERGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of oncology; conducting clinical trials
ai-emerge

General Information

Serial Number87929768
Word MarkAI-EMERGE
Filing DateMonday, May 21, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 27, 2026
Registration Number5835801
Registration DateTuesday, August 13, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 23, 2018

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of oncology; conducting clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 27, 2026
Primary Code042
First Use Anywhere DateSunday, December 31, 2017
First Use In Commerce DateSunday, December 31, 2017

Trademark Owner History

Party NameFreenome Holdings, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US
Party NameFreenome Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US
Party NameFreenome Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US

Trademark Events

Event DateEvent Description
Thursday, May 24, 2018NEW APPLICATION ENTERED
Wednesday, May 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 12, 2018ASSIGNED TO EXAMINER
Wednesday, September 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 23, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 17, 2019TEAS STATEMENT OF USE RECEIVED
Monday, July 8, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 17, 2019USE AMENDMENT FILED
Monday, July 8, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, July 8, 2019SU - NON-FINAL ACTION - WRITTEN
Monday, July 8, 2019NON-FINAL ACTION E-MAILED
Monday, July 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 10, 2019SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, July 10, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, July 10, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 11, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 13, 2019REGISTERED-PRINCIPAL REGISTER
Monday, February 14, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 14, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 13, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 27, 2026CANCELLED SEC. 8 (6-YR)

Related Keywords

emerge field clinical trials providing information research medical scientific conducting oncology